This past November 11th at the University of Miami LifeBridge got to participate in the Harvard Business School Alumni Angels of South Florida Pitch Contest. Thirty-one companies presented their business opportunity to a group of judges prior to the meeting. LifeBridge was among three finalists chosen to present on the 11th. The 1st place prize is the opportunity to present in front of all the Harvard Business School investment angels of South Florida. LifeBridge got 1st runner up… sort of.

After the awards ceremony one of the organizers of the event pulled CEO, Peter Travers aside and informed him that they were considering awarding LifeBridge the opportunity to present in front of the larger angel group just like the 1st place winner. On Nov 14th LifeBridge got the news that it was also awarded the opportunity to present to the larger Harvard group on Nov 30th. Evidently the voting between 1st and 2nd place was so close they decided to award both companies the opportunity. LifeBridge is humbled and grateful for this important exposure.

Participants at the event were eager to learn about the science behind tumor treating fields and how it has the potential to transform the treatment of metastatic cancer.
LifeBridge continues to look for investors to help move it through the next level of development as it continually moves toward getting its therapy to those who need it most, all while delivering outstanding returns to its investors.


For more information media should contact –

Peter Travers, LifeBridge Innovations, 407-416-1099,

Rafael Caamano, UCF Business Incubation Program, 407-408-4297,

About LifeBridge Innovations, PBC: LifeBridge Innovations, PBC was founded in January of 2015 by a marketing professional, a private investor, and two senior engineers. The company is headquartered in Longwood, FL and has been accepted into the University of Central Florida Business Incubation program, in Winter Springs, as a full participant.

The managing member, Mr. Travers, and his late wife, Laurie, were immersed in the culture of cancer for almost 18 years, which led to the work with TTF (Tumor Treating Fields) technology. Laurie’s Breast Cancer was discovered as stage 3, progressing to stage 4 within the first year. She experienced 12 reoccurrences, 9 rounds of chemotherapy, four series of radiation treatments, thoracentesis to remove fluid from the pleura around her lung 9 times, and participation in two clinical trials.    Treatment with TTF extended Laurie’s life an additional 3 years. Improvement and stability only occurred where Laurie used TTF.

LifeBridge Innovations was founded because of this experience. The objective of the Company is to extend and improve the quality of life for patients with advanced stage cancer by providing a 4th treatment option with their TTF System called the LB10000.  The LifeBridge LB10000 offers the hope of extended survival, improved quality of life, and freedom from the toxic side effects of chemotherapy or radiation. Patients with late stage cancer often do not survive long enough to try new breakthrough treatments. For more information, visit

About the UCF Business Incubation Program:

The University of Central Florida Business Incubation Program is a community resource that provides early-stage companies with the tools, training and infrastructure to become financially stable, high growth/impact enterprises. Since 1999, this award-winning program has provided vital business development resources resulting in over 300 local startup companies reaching their potential faster and graduating into the community where they continue to grow and positively impact the local economy.

With eight facilities throughout the region, the UCF Business Incubation Program is an economic development partnership between the University of Central Florida, the Corridor, Orange, Osceola, Seminole and Volusia Counties, and the cities of Kissimmee, Orlando and Winter Springs. For the 2017/2018 fiscal years, the activities of these participating firms have helped to sustain more than 6,725 local jobs and have had a cumulative impact of over $725 million on regional GDP and over $1.3 billion on regional sales. During the same period, the program has returned more than $12.00 in state and local taxes for every $1.00 invested in the program. In addition, for every $1.00 of public investment the firms also produced $118 of additional regional GDP and $226 of regional sales.  For more information, visit